European Healthtech startup funding raised during April 2014.
In April 2014, 17 European Healthtech companies raised a combined €151M across 17 funding rounds, down 1.8% versus April 2013. Sweden led by capital raised, and ABRT Venture Fund was the most active investor. Data as of 7 Aug 2026.
1 exit.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Wilson Therapeutics | Other | Apr 2014 | €36M |
| CRISPR Therapeutics | Series A | Apr 2014 | €23M |
| Voluntis | Series D+ | Apr 2014 | €21M |
| Sequana Medical | Series C |
| Apr 2014 |
| €17M |
| Bima | Series B | Apr 2014 | €16M |
| Lifeline Ventures Oy | Other | Apr 2014 | €15M |
| OxThera | Other | Apr 2014 | €7.7M |
| Lifesum | Series A | Apr 2014 | €4.9M |
| ProteoMediX | Series B | Apr 2014 | €2.6M |
| Nanolive | Early VC | Apr 2014 | €2.5M |
| Big Health | Series A | Apr 2014 | €2.4M |
| Zesty | Early VC | Apr 2014 | €1.5M |
| Network Locum | Seed | Apr 2014 | €845k |
| Mathym | Seed | Apr 2014 | €600k |
| Alovita | Other | Apr 2014 | €120k |
